A point mutation in an invariant splice donor site leads to exon skipping in two unrelated Dutch patients with dihydropyrimidine dehydrogenase deficiency
- 25 January 1996
- journal article
- case report
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 19 (5) , 645-654
- https://doi.org/10.1007/bf01799841
Abstract
Dihydropyrimidine dehydrogenase (DPD) deficiency is an autosomal recessive disease characterized by thymine-uraciluria and associated with a variable clinical phenotype. In order to identify the molecular defect underlying complete DPD deficiency in a Dutch patient previously shown to have a 165 base pair deletion in the mature DPD mRNA, we cloned the genomic region encompassing the skipped exon and its flanking intron sequences. Sequence analysis revealed that the patient was homozygous for a single G→A point mutation in the invariant GT dinucleotide splice donor site downstream of the skipped exon. The same mutation was identified in another, unrelated, Dutch patient. Because this mutation destroys a uniqueMaeII restriction site, rapid screening using restriction enzyme cleavage of the amplified genomic region encompassing this mutation is possible. Analysis of 50 controls revealed no individuals heterozygous for this mutationKeywords
This publication has 29 references indexed in Scilit:
- Human Polymorphism in Drug Metabolism: Mutation in the Dihydropyrimidine Dehydrogenase Gene Results in Exon Skipping and Thymine UracilureaDNA and Cell Biology, 1995
- Purification, characterization and inhibition of dihydropyrimidinase from rat liverEuropean Journal of Biochemistry, 1994
- Comparison of dihydropyrimidine dehydrogenase from human, rat, pig and cow liver: Biochemical and immunological propertiesBiochemical Pharmacology, 1993
- The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: Causes and consequencesHuman Genetics, 1992
- Familial deficiency of dihydropyrimidine dehydrogenase. Biochemical basis for familial pyrimidinemia and severe 5-fluorouracil-induced toxicity.Journal of Clinical Investigation, 1988
- Dihydropyrimidine dehydrogenase deficiencyJournal of the Neurological Sciences, 1987
- A compensatory base change in U1 snRNA suppresses a 5′ splice site mutationCell, 1986
- Dihydropyrimidine dehydrogenase deficiency leading to thymine-uraciluria. An inborn error of pyrimidine metabolismClinica Chimica Acta; International Journal of Clinical Chemistry, 1984
- Elevated urine, blood and cerebrospinal fluid levels of uracil and thymine in a child with dihydrothymine dehydrogenase deficiencyClinica Chimica Acta; International Journal of Clinical Chemistry, 1984
- Degradation of pyrimidines and pyrimidine analogs—Pathways and mutual influencesPharmacology & Therapeutics, 1980